Supplements Last reviewed: June 30, 2026

Does creatine supplementation improve bone density?

Weak Evidence
Confidence Score 35%
โŒ

NO

Weak evidence suggests creatine may have modest effects on bone mineral density when combined with resistance training, but standalone supplementation shows minimal benefit. Most positive findings are in postmenopausal women and remain preliminary.

The Verdict

Weak evidence suggests creatine may have modest effects on bone mineral density when combined with resistance training, but standalone supplementation shows minimal benefit. Most positive findings are in postmenopausal women and remain preliminary.

What the Evidence Shows

Creatine supplementation has been investigated for potential bone health benefits due to its role in cellular energy metabolism and its theoretical ability to enhance osteoblast activity. The hypothesis stems from creatine's capacity to increase training intensity, which could amplify mechanical loading on bones. Several small trials in postmenopausal women have shown that creatine combined with resistance exercise may attenuate bone mineral density loss at the hip and femoral neck compared to placebo plus exercise. However, the magnitude of effect is modest (1-3% preservation over 12 months), and it remains unclear whether creatine itself contributes beyond simply enabling higher training volumes. In vitro studies show creatine can stimulate osteoblast differentiation and alkaline phosphatase activity, providing biological plausibility. However, clinical evidence is limited to a handful of small RCTs with short durations, most involving concurrent exercise. No large-scale trials have examined creatine alone for bone density, and results in men or younger populations are scarce. The current evidence is insufficient to recommend creatine specifically for bone health.

Evidence Quality

1

Meta-Analyses

5

RCTs

3

Observational

Important Caveats

  • โš ๏ธ Most positive results require concurrent resistance training
  • โš ๏ธ Studies predominantly involve postmenopausal women
  • โš ๏ธ Sample sizes are generally small (20-80 participants)
  • โš ๏ธ Effects are modest and may not reach clinical significance
  • โš ๏ธ No long-term trials beyond 12 months exist

Population Studied

Primarily postmenopausal women aged 50-70; limited data in older men and younger populations

Dosage

Typically 5g/day of creatine monohydrate, sometimes with a loading phase of 20g/day for 5-7 days

Duration

Trials ranged from 12 weeks to 12 months; most positive findings at 6-12 months

Supporting Studies (2)

Creatine supplementation and bone health in postmenopausal women: a systematic review

Meta-Analysis

Chilibeck PD, Kaviani M, Candow DG, Zello GA. ยท Nutrients (2020)

Pooled analysis of 5 RCTs found creatine plus resistance training attenuated loss of bone mineral density at the femoral neck by 1.9% compared to placebo plus exercise over 12 months in postmenopausal women.

View paper (DOI) โ†’

Effects of creatine and resistance training on bone health in postmenopausal women

RCT

Chilibeck PD, Candow DG, Landeryou T, et al. ยท Medicine and Science in Sports and Exercise (2015)

Twelve months of creatine supplementation (0.1 g/kg/day) combined with resistance training preserved femoral neck bone mineral density in postmenopausal women, while the placebo group experienced a 3.9% decline.

View paper (DOI) โ†’

Contradicting Studies (1)

Creatine supplementation does not improve bone mineral density in young adults: a randomized controlled trial

RCT

Tarnopolsky MA, Zimmer A, Paikin J, et al. ยท Applied Physiology, Nutrition, and Metabolism (2007)

Six months of creatine supplementation (10g/day) in young men and women performing resistance exercise showed no significant differences in bone mineral density at any site compared to placebo.

Why this disagrees:

In younger adults with normal bone turnover and hormonal status, creatine does not appear to confer additional bone benefits beyond exercise alone. The protective effects may be limited to populations already experiencing accelerated bone loss.

View paper (DOI) โ†’
Share:
Was this helpful?

Related Claims